All News #Library
Others
BioCity’s SC0062 Gets Breakthrough Tag for Diabetic Kidney Dx
25 Jun 2025 //
PR NEWSWIRE
BioCity To Present SC0062 Data At ASN 2024 And In JASN
14 Oct 2024 //
PR NEWSWIRE
BioCity`s Granted BTD By NMPA For IgA Nephropathy with Proteinuria
26 Sep 2024 //
PR NEWSWIRE
BioCity`s SC0062 Meets Primary Endpoint In Phase 2 IgA Nephropathy Trial
08 Jul 2024 //
PR NEWSWIRE
BioCity Announces Enrollment Completion of the IgAN Cohort in SC0062
26 Feb 2024 //
PR NEWSWIRE
BioCity announces FDA clearance of Investigational NDA for CD3/EGFR antibody
07 Aug 2023 //
PR NEWSWIRE
BioCity Announces Initiation of a Phase 2 Trial for SC0062,
21 Jun 2023 //
PR NEWSWIRE

Market Place
Sourcing Support